Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PACTR202304865602085Phase 3Not yet recruiting
Phase 3 trial of morphine and nalbuphine in postoperative pain (2 arms), sponsored by Dr. Mona Raafat Elghamry. Primary endpoint: Duration of effective analgesia. Planned start May 2023; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on PACTR202304865602085.